Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y L Kim

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Transplantation Proceedings|December 26, 2001
The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial)D K Cho, J H Kim, S H Park, et al.
Cell Death and Differentiation|May 7, 2013
ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by destabilizing p21(WAF1.)J Han, Y-L Kim, K-W Lee, et al.
Transplantation Proceedings|June 7, 2017
Effect of Changes in Body Mass Index on Cardiovascular Outcomes in Kidney Transplant RecipientsK Y Kim, J-H Cho, H-Y Jung, et al.
Tissue Antigens|June 16, 2010
Interleukin-18, transforming growth factor-β, and vascular endothelial growth factor gene polymorphisms and susceptibility to primary glomerulonephritisH-J Choi, J-H Cho, J-C Kim, et al.
Transplantation Proceedings|June 4, 2013
Risk factors for recurrent urinary tract infection in kidney transplant recipientsJ-H Lim, J-H Cho, J-H Lee, et al.
Transplantation Proceedings|May 8, 2018
Distribution of Anti-ABO Immunoglobulin G Subclass and C1q Antibody in ABO-incompatible Kidney TransplantationK H Lee, D I Won, J-M Yook, et al.
Leukemia|September 10, 2004
Pretransplant imatinib can improve the outcome of nonmyeloablative stem cell transplantation without increasing the morbidity in Philadelphia chromosome-positive chronic myeloid leukemiaD-W Kim, Y-J Chung, S Lee, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Transplantation Proceedings|December 26, 2001
The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial)D K Cho, J H Kim, S H Park, et al.
Cell Death and Differentiation|May 7, 2013
ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by destabilizing p21(WAF1.)J Han, Y-L Kim, K-W Lee, et al.
Transplantation Proceedings|June 7, 2017
Effect of Changes in Body Mass Index on Cardiovascular Outcomes in Kidney Transplant RecipientsK Y Kim, J-H Cho, H-Y Jung, et al.
Tissue Antigens|June 16, 2010
Interleukin-18, transforming growth factor-β, and vascular endothelial growth factor gene polymorphisms and susceptibility to primary glomerulonephritisH-J Choi, J-H Cho, J-C Kim, et al.
Transplantation Proceedings|June 4, 2013
Risk factors for recurrent urinary tract infection in kidney transplant recipientsJ-H Lim, J-H Cho, J-H Lee, et al.
Transplantation Proceedings|May 8, 2018
Distribution of Anti-ABO Immunoglobulin G Subclass and C1q Antibody in ABO-incompatible Kidney TransplantationK H Lee, D I Won, J-M Yook, et al.
Leukemia|September 10, 2004
Pretransplant imatinib can improve the outcome of nonmyeloablative stem cell transplantation without increasing the morbidity in Philadelphia chromosome-positive chronic myeloid leukemiaD-W Kim, Y-J Chung, S Lee, et al.
Pageof 6